Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: Clin Cancer Res. 2015 Dec 2;22(10):2377–2385. doi: 10.1158/1078-0432.CCR-15-1811

Table 2.

Wild-type melanomas (BRAF/NRAS/KIT WT) patients harbor mutations in known oncogenes and tumor suppressors.

WT melanoma patients Somatic mutations

07-249 KRAS
06-004 KRAS, TP53, RB1
03-173 HRAS
10-071 TP53
06-050 ERBB4
07-021 PIK3CA
09-241 NOTCH, EZH2
06-092 -
11-047 -